Oncothyreon to Present at Future Leaders in the Biotech Industry Conference

SEATTLE, April 13, 2012 /CNW/ - Oncothyreon Inc. (Nasdaq: ONTY) announced today that Robert Kirkman, M.D., President and Chief Executive Officer, will be presenting at the 19th Annual Future Leaders in the Biotech Industry Conference, presented by BioCentury and Thomson Reuters, in New York on Friday, April 20, 2012 at 9:30 a.m. Eastern.

A live and archived webcast of the presentation will be accessible by visiting the Oncothyreon website www.oncothyreon.com under the "News & Events" section.

About Oncothyreon
Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit www.oncothyreon.com.

Investor and Media Relations Contact:
Julie Rathbun
Rathbun Communications
206-769-9219
[email protected]

ONCOTHYREON INC., 2601 Fourth Avenue, Suite 500, Seattle, WA 98121
Tel: [phone]   Fax:  [phone]
http://www.oncothyreon.com